Investegate |PureTech Health PLC Announcements | PureTech Health PLC: PRTC Receives $6.5M; Imbrium to Develop LYT-503
Investegate announcements from PureTech Health PLC, PRTC Receives $6.5M; Imbrium to Develop LYT-503
Stay updated with breaking news from Rob Winder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from PureTech Health PLC, PRTC Receives $6.5M; Imbrium to Develop LYT-503
Investegate announcements from PureTech Health PLC, PureTech's Gelesis Presents Plenity Data at AACE
Investegate announcements from PureTech Health PLC, PureTech's Akili Secures $160M in Financing
Preclinical research suggests that restoring lymphatic flow in the brain has the potential to address a range of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and associated neuroinflammation Additionally, research found that improving lymphatic flow could enhance the efficacy of antibody therapies against aberrant proteins, potentially opening a new avenue for disease management PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discoveri...
PureTech Announces Annual Results for Year Ended December 31, 2020 By Staff 2 seconds ago Strong capital base and cash runway extended into the first quarter of 2025, with PureTech level cash and cash equivalents of $443.4 million as of March 31, 2021 1 ($349.4 million as of December 31, 2020 2) and consolidated cash and cash equivalents of $486.5 million as of March 31, 2021 3 ($403.9 million as of December 31, 2020 4) Advancement of Wholly Owned Pipeline with four clinical trial initiations and one successful readout, with three clinical trials ongoing Significant milestones across PureT...